Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.
about
Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders.Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin diseaseADAM33, a new candidate for psoriasis susceptibility.Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population.Replication of association between ADAM33 polymorphisms and psoriasis.High prevalence of skin diseases and need for treatment in a middle-aged population. A Northern Finland Birth Cohort 1966 studySystematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis.Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Vitamin D and psoriasis pathology in the Mediterranean region, Valencia (Spain)'On the surface': a qualitative study of GPs' and patients' perspectives on psoriasis.Subjective stress reactivity in psoriasis - a cross sectional study of associated psychological traitsDeterminants of quality of life in psoriasis patients: a cluster analysis of 50 patientsImpact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis.German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).The challenges of assessing patients' medication beliefs: a qualitative study.Skin diseases among elderly inhabitants of Bialystok, Poland.Epidemiology of psoriasis. Review and the German perspective.The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.Moderate and severe plaque psoriasis: cost-of-illness study in Italy.Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.Feasibility of establishing deletion of the late cornified envelope genes LCE3B and LCE3C as a susceptibility factor for psoriasisThe role of focal infections in the pathogenesis of psoriasis and chronic urticaria.Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13.Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locusQuality of life measures in psoriasis: a critical appraisal of their quality.Psychosomatic factors in pruritus.More Biologic Therapies Expected To Treat Advanced Plaque Psoriasis.Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21.The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures.An Italian study on psoriasis and depression.Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5.Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database.Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry.Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis.The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial.
P2860
Q24816472-D2BB1518-896C-42A7-88D7-293900D1E102Q26828789-0A49765A-BD90-425B-83C0-88D0191714D7Q33299472-F0F89E8E-AF7C-4DBD-96C4-AA2A78472739Q33325907-B8F12BDC-C3E6-4B10-956B-59C9A49240ECQ33344508-8651A51D-C32A-44C9-8980-D1D4BB6EAC44Q33728094-D1973F05-2A74-4368-97E9-95B6F76B9D4AQ33884648-DBE9B7EE-E848-45BC-9326-268FDBF4B175Q34449302-26EC6E27-67AD-47C7-82E2-58F7CB850EF2Q34721703-B2FE513F-FC31-4396-A068-D07C64E561CAQ34773007-7C928E81-A9AE-4F55-BF70-DA87EC8FCBA8Q35020447-FDAC5432-3402-4980-83F7-A3356A3F22B6Q35579958-C5050F2A-55D0-47A2-9E7F-EC156B0ABECDQ35749056-A05458B9-5925-4672-A8C0-69CC56F37F41Q35862134-DCABEB0E-2556-447A-8FDA-B2612E170432Q35875481-37F9CD4D-BCF7-44E3-953D-3579ED66E467Q36273438-D55307DF-065E-44FE-9951-881AF2903E0CQ36367994-F7D184FB-3D34-4711-AA47-354195B22B2EQ36481432-1141FDF6-0E07-4CAB-8EF0-91DF61885122Q36602668-614E67B6-B37F-4FC4-AC59-F55CCF43DFE5Q36823606-A1AF6DF1-CDE9-4D14-B458-C2042F42D528Q36914874-4BFADBB5-E90A-4DF3-B209-ED923B5DDC4EQ37031620-2E336897-875F-4074-BE8A-01DD8F7834D8Q37327150-CCA06253-CDE6-491C-BC76-E6355C4B07ABQ37334183-66E7ACFB-EA3B-41BF-AB10-DF81EC98BAE3Q37622768-8FBAA0CB-A11F-41B7-B54F-944C8C25C79CQ37717840-CD1D21A2-349F-4789-9249-18C650A5AE20Q39806687-AF5A2D79-2823-44BE-96AA-FD6EF17BD113Q40269632-4C0CAA72-C5D9-4318-B107-E60986D5296CQ40725419-96C08322-A7C8-4BC8-A853-C4CF1BF8EEE2Q40829966-81923C8C-D503-48AD-98DD-87D3220173D2Q41920185-7B2C0670-EE97-45BB-BB18-D4CADB3FD8D2Q41967507-00AD983C-311C-4CC9-9DCD-5C47F7C679C9Q42698848-1DFA05B7-BE2C-440B-8A03-67D550833646Q44133005-5ED3FAA0-AF4A-42DC-A7AD-1316DF936D49Q45101688-9FD6A929-4E29-4808-8F15-BF464B7704FFQ46683887-35573490-C7EA-483C-9FC7-9CB3F3F45AF0Q47100186-FB421396-F803-4469-BCD5-BFC26B4F6FD8Q47126973-CDF645DA-16BD-4B8D-94B1-A4EC3F07BB0EQ47672947-3DCAB4ED-C854-47D0-9371-481047D37239Q48559078-4B8870E2-7B84-4C5C-B595-BF1512C74F17
P2860
Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Psoriasis in the community: pr ...... attitudes towards the disease.
@en
Psoriasis in the community: pr ...... attitudes towards the disease.
@nl
type
label
Psoriasis in the community: pr ...... attitudes towards the disease.
@en
Psoriasis in the community: pr ...... attitudes towards the disease.
@nl
prefLabel
Psoriasis in the community: pr ...... attitudes towards the disease.
@en
Psoriasis in the community: pr ...... attitudes towards the disease.
@nl
P1476
Psoriasis in the community: pr ...... attitudes towards the disease.
@en
P2093
Hutchinson PE
P304
P356
10.1046/J.1365-2133.1996.D01-1035.X
P407
P577
1996-10-01T00:00:00Z